• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤中p15启动子高甲基化的临床病理意义:一项荟萃分析

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.

作者信息

Wei Bing, Yang Shuhua, Zhang Bo, Feng Yong

机构信息

Department of Orthopaedic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

出版信息

Onco Targets Ther. 2016 Jul 1;9:4015-22. doi: 10.2147/OTT.S102733. eCollection 2016.

DOI:10.2147/OTT.S102733
PMID:27445492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4936815/
Abstract

Published studies reported that loss of function of the p15(INK4B) gene is caused by hypermethylation; however, whether or not the inactivation is associated with the incidence and clinical significance of multiple myeloma (MM) remains unclear. In this study, we performed a meta-analysis to quantitatively determine the effects of p15 hypermethylation on the incidence of MM. The related research articles in English and Chinese languages were evaluated. The data were extracted and assessed independently. The pooled data were analyzed and odds ratios were calculated and summarized. Sixteen eligible studies were selected for final analysis. We demonstrated that p15 hypermethylation is significantly higher in MM than that in normal bone marrow, as well as monoclonal gammopathy of undetermined significance. However, aberrant p15 hypermethylation was not significantly higher in advanced MM than that in early-stage MM. The results of this study reveal that p15 hypermethylation is correlated with an increased risk in the progression of monoclonal gammopathy of undetermined significance to MM. p15 hypermethylation, which induces the loss of function of the p15 gene, plays a critical role in the early tumorigenesis of MM and serves as a reputable diagnostic marker and potential drug target.

摘要

已发表的研究报告称,p15(INK4B)基因功能丧失是由高甲基化引起的;然而,这种失活是否与多发性骨髓瘤(MM)的发病率及临床意义相关仍不清楚。在本研究中,我们进行了一项荟萃分析,以定量确定p15高甲基化对MM发病率的影响。对中英文相关研究文章进行了评估。数据被独立提取和评估。对汇总数据进行分析,并计算和总结比值比。选择16项符合条件的研究进行最终分析。我们证明,MM中p15高甲基化显著高于正常骨髓以及意义未明的单克隆丙种球蛋白病。然而,晚期MM中异常p15高甲基化并不显著高于早期MM。本研究结果表明,p15高甲基化与意义未明的单克隆丙种球蛋白病进展为MM的风险增加相关。p15高甲基化诱导p15基因功能丧失,在MM的早期肿瘤发生中起关键作用,可作为可靠的诊断标志物和潜在的药物靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/d28f781f9667/ott-9-4015Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/7c17e668f395/ott-9-4015Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/b1a2bcdfcb52/ott-9-4015Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/f914bd0d190e/ott-9-4015Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/e94bf3a82765/ott-9-4015Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/d28f781f9667/ott-9-4015Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/7c17e668f395/ott-9-4015Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/b1a2bcdfcb52/ott-9-4015Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/f914bd0d190e/ott-9-4015Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/e94bf3a82765/ott-9-4015Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af9/4936815/d28f781f9667/ott-9-4015Fig5.jpg

相似文献

1
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.多发性骨髓瘤中p15启动子高甲基化的临床病理意义:一项荟萃分析
Onco Targets Ther. 2016 Jul 1;9:4015-22. doi: 10.2147/OTT.S102733. eCollection 2016.
2
Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma.p15INK4B在多发性骨髓瘤中的临床病理意义及潜在药物靶点
Drug Des Devel Ther. 2014 Oct 31;8:2129-36. doi: 10.2147/DDDT.S71088. eCollection 2014.
3
Clinicopathological significance of the hypermethylation in multiple myeloma, a systematic review and meta-analysis.多发性骨髓瘤中高甲基化的临床病理意义:一项系统评价和荟萃分析
Oncotarget. 2017 Jun 27;8(47):83270-83279. doi: 10.18632/oncotarget.18742. eCollection 2017 Oct 10.
4
Role of and promoter methylation in patients with lung cancer: a systematic meta-analysis.[具体基因名称]和[具体基因名称]启动子甲基化在肺癌患者中的作用:一项系统的荟萃分析。 需注意,原文中“Role of and promoter methylation”这里两个“ ”处应是具体基因名称,你提供的原文信息不完整,以上是根据格式要求进行的大致翻译,实际准确翻译需补充完整具体基因名称。
Onco Targets Ther. 2016 Nov 11;9:6977-6985. doi: 10.2147/OTT.S117161. eCollection 2016.
5
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.RUNX3在非小细胞肺癌中的临床病理意义及潜在药物靶点:一项荟萃分析
Drug Des Devel Ther. 2015 Jun 3;9:2855-65. doi: 10.2147/DDDT.S76358. eCollection 2015.
6
Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.维甲酸受体β2(RARβ2)、死亡相关蛋白激酶(DAPK)、人错配修复蛋白(hMLH1)、p14和p15的启动子高甲基化与乳腺癌进展相关:一项遵循PRISMA规范的荟萃分析。
Medicine (Baltimore). 2018 Dec;97(51):e13666. doi: 10.1097/MD.0000000000013666.
7
Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis.RUNX3 高甲基化频率与结直肠癌的临床意义及相关性:一项荟萃分析。
Onco Targets Ther. 2014 Jul 10;7:1237-45. doi: 10.2147/OTT.S62103. eCollection 2014.
8
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.T-钙黏蛋白在非小细胞肺癌中的临床病理意义及潜在药物靶点
Drug Des Devel Ther. 2014 Dec 19;9:207-16. doi: 10.2147/DDDT.S74259. eCollection 2015.
9
p15 Loss of Expression by Promoter Hypermethylation Adds to Leukemogenesis and Confers a Poor Prognosis in Acute Promyelocytic Leukemia Patients.p15因启动子高甲基化导致的表达缺失促进急性早幼粒细胞白血病的白血病发生并预示患者预后不良。
Cancer Res Treat. 2017 Jul;49(3):790-797. doi: 10.4143/crt.2016.108. Epub 2016 Dec 5.
10
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.FHIT在乳腺癌中的临床病理意义及药物靶点潜力:一项荟萃分析与文献综述
Drug Des Devel Ther. 2015 Oct 1;9:5439-45. doi: 10.2147/DDDT.S89861. eCollection 2015.

引用本文的文献

1
The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression.亚油酸酰胺肟和 5-Aza-2'-脱氧胞苷对不同 IL-6 表达骨髓瘤细胞系中 DNMT3B 表达的表观遗传学影响。
Mol Med Rep. 2022 Oct;26(4). doi: 10.3892/mmr.2022.12837. Epub 2022 Aug 31.
2
Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.多发性骨髓瘤的表观遗传调控突变与表观遗传治疗
Curr Opin Hematol. 2017 Jul;24(4):336-344. doi: 10.1097/MOH.0000000000000358.

本文引用的文献

1
Novel agents and new therapeutic approaches for treatment of multiple myeloma.用于治疗多发性骨髓瘤的新型药物和新治疗方法。
World J Methodol. 2014 Jun 26;4(2):73-90. doi: 10.5662/wjm.v4.i2.73.
2
Aberrant promoter methylation of p15 (INK⁴b) and p16 (INK⁴a) genes may contribute to the pathogenesis of multiple myeloma: a meta-analysis.p15(INK⁴b)和p16(INK⁴a)基因的异常启动子甲基化可能与多发性骨髓瘤的发病机制有关:一项荟萃分析。
Tumour Biol. 2014 Sep;35(9):9035-43. doi: 10.1007/s13277-014-2054-2. Epub 2014 Jun 8.
3
Microenvironment and multiple myeloma spread.
微环境与多发性骨髓瘤的扩散
Thromb Res. 2014 May;133 Suppl 2:S102-6. doi: 10.1016/S0049-3848(14)50017-5.
4
Multiple myeloma maintenance therapy: a review of the pharmacologic treatment.多发性骨髓瘤维持治疗:药物治疗综述
J Oncol Pharm Pract. 2015 Feb;21(1):36-51. doi: 10.1177/1078155213514468. Epub 2014 Jan 6.
5
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤:生物学见解与早期治疗策略
Hematology Am Soc Hematol Educ Program. 2013;2013:478-87. doi: 10.1182/asheducation-2013.1.478.
6
DNA methylation and differentiation: silencing, upregulation and modulation of gene expression.DNA 甲基化与分化:基因表达的沉默、上调和调控。
Epigenomics. 2013;5(5):553-68. doi: 10.2217/epi.13.43.
7
DNA methylation and cancer diagnosis.DNA 甲基化与癌症诊断。
Int J Mol Sci. 2013 Jul 18;14(7):15029-58. doi: 10.3390/ijms140715029.
8
DNA methylation data analysis and its application to cancer research.DNA 甲基化数据分析及其在癌症研究中的应用。
Epigenomics. 2013 Jun;5(3):301-16. doi: 10.2217/epi.13.26.
9
Lenalidomide treatment for multiple myeloma: systematic review and meta-analysis of randomized controlled trials.来那度胺治疗多发性骨髓瘤:随机对照试验的系统评价和荟萃分析。
PLoS One. 2013 May 14;8(5):e64354. doi: 10.1371/journal.pone.0064354. Print 2013.
10
Bortezomib for the treatment of previously untreated multiple myeloma.硼替佐米治疗未经治疗的多发性骨髓瘤。
Immunotherapy. 2013 Apr;5(4):327-52. doi: 10.2217/imt.13.14.